Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of G alpha 16 and CD34

Citation
M. Pfeilstocker et al., Hematopoietic recovery after IEV chemotherapy for malignant lymphoma followed by different cytokines can be monitored by analysis of G alpha 16 and CD34, AM J HEMAT, 64(3), 2000, pp. 156-160
Citations number
30
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF HEMATOLOGY
ISSN journal
03618609 → ACNP
Volume
64
Issue
3
Year of publication
2000
Pages
156 - 160
Database
ISI
SICI code
0361-8609(200007)64:3<156:HRAICF>2.0.ZU;2-F
Abstract
The hematopoiesis-specific G protein alpha subunit G alpha 16 is a specific element in the signal transduction of the early hematopoietic cytokine net work. As G alpha 16 mRNA can be detected in early hematopoietic progenitor cells, RT-PCR for G alpha 16 can be used as a sensitive marker of hematopoi etic activity. The aim of this study was to test the possible use of Gale d eterminations for monitoring cytokine effects on hematopoietic recovery aft er chemotherapy in patients. We correlated presence of G alpha 16 mRNA and CD34 surface antigen with hematopoietic recovery in six lymphoma patients u ndergoing salvage therapy with different cytokine support (IEV followed by G-CSF, IL-3, or placebo). Regardless of different cytokine schedules with d ifferent time courses, hematopoietic recovery was always preceded by transc ription of Gale, Monitoring the expression of Ga16 mRNA by RT-PCR is a high ly sensitive diagnostic tool for analyzing hematopoietic recovery after che motherapy and for characterizing the effects of cytokines on hematopoiesis. (C) 2000 Wiley-Liss, Inc.